SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-14-001970
Filing Date
2014-08-29
Accepted
2014-08-29 17:05:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g09543001_08292014.htm SC 13G 131231
2 JOINT FILING AGREEMENT ex991sc13g09543001_08292014.htm EX-99.1 15255
  Complete submission text file 0000921895-14-001970.txt   148011
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81821 | Film No.: 141075848
SIC: 2834 Pharmaceutical Preparations

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

IRS No.: 000000000
Type: SC 13G